Bridge City Capital’s Catalyst Pharmaceutical CPRX Stock Holding History

Bridge City Capital’s Portfolio CPRX Stock Details CPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.8M	Sell	152,684 -3,005	-2%	-$88.7K	1.1%	29
2026 Q1	$3.85M	Sell	155,689 -994	-0.6%	-$23.7K	1.07%	30
2025 Q4	$3.66M	Sell	156,683 -25,613	-14%	-$571K	1.07%	33
2025 Q3	$3.59M	Buy	182,296 +66,415	+57%	+$1.37M	0.96%	41
2025 Q2	$2.51M	Sell	115,881 -1,493	-1%	-$35.2K	0.71%	64
2025 Q1	$2.85M	Buy	+117,374	New	+$2.64M	0.85%	52

Other funds holding CPRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bridge City Capital's CPRX Position: Q2 2026 in Review

Bridge City Capital reduced its Catalyst Pharmaceutical (CPRX) stake by 1.9% in Q2 2026, selling an estimated $88.7K and leaving 152,684 shares worth $4.8M. The position accounts for 1.1% of the portfolio, ranked #29.

Bridge City Capital first reported a position in CPRX in Q1 2025 and has held it in 6 quarters since. 396 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

Bridge City Capital held 152,684 shares of Catalyst Pharmaceutical worth $4.8M as of Q2 2026.
Bridge City Capital sold 3,005 Catalyst Pharmaceutical shares in Q2 2026, an estimated $88.7K.
Catalyst Pharmaceutical made up 1.1% of Bridge City Capital's portfolio in Q2 2026, its #29 holding.
Bridge City Capital first reported a position in Catalyst Pharmaceutical in Q1 2025 and has held it in 6 quarters since.
396 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Bridge City Capital's 13F filing for Q2 2026, filed 11 Aug 2026.